These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 10810759)

  • 1. Formulation design studies of atenolol tablets.
    Moneghini M; Carcano A; Perissutti B; Rubessa F
    Pharm Dev Technol; 2000; 5(2):297-301. PubMed ID: 10810759
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative study of different formulations of atenolol.
    Yasmeen R; Shoaib MH; Khalid H
    Pak J Pharm Sci; 2005 Jan; 18(1):47-51. PubMed ID: 16431383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Preparation of atenolol monolithic osmotic pump tablets].
    Liu LX; Che BJ; Xu Q
    Yao Xue Xue Bao; 2006 May; 41(5):457-60. PubMed ID: 16848324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zero-order release of aspirin, theophylline and atenolol in water from novel methylcellulose glutarate matrix tablets.
    Khairuzzaman A; Ahmed SU; Savva M; Patel NK
    Int J Pharm; 2006 Aug; 318(1-2):15-21. PubMed ID: 16621361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation development and optimization: Encapsulated system of Atenolol and Glyburide.
    Maboos M; Yousuf RI; Shoaib MH
    Pak J Pharm Sci; 2016 Mar; 29(2):569-77. PubMed ID: 27087100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Production and characterization of an atenolol-reticulated povodone tablet].
    Dobrecky J; Bregni C; Lamas MC; Cancelo G; Estévez SM
    Boll Chim Farm; 2000; 139(5):209-12. PubMed ID: 11213439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral sustained delivery of atenolol from floating matrix tablets-formulation and in vitro evaluation.
    Srivastava AK; Wadhwa S; Ridhurkar D; Mishra B
    Drug Dev Ind Pharm; 2005 May; 31(4-5):367-74. PubMed ID: 16093202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulation and stability evaluation of extemporaneously prepared atenolol capsules from crushed atenolol tablets.
    Zaid AN; Malkieh N; Kharoaf M; Abu Ghoush A; Al-Ramahi R
    Int J Pharm Compd; 2012; 16(4):342-6. PubMed ID: 23050394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulation and optimization of controlled release mucoadhesive tablets of atenolol using response surface methodology.
    Singh B; Chakkal SK; Ahuja N
    AAPS PharmSciTech; 2006 Jan; 7(1):E3. PubMed ID: 16584161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development, validation and stability study of pediatric atenolol syrup.
    Foppa T; Murakami FS; Silva MA
    Pharmazie; 2007 Jul; 62(7):519-21. PubMed ID: 17718193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimization of fluid bed formulations of metoprolol granules and tablets using an experimental design.
    Tomuţă I; Alecu C; Rus LL; Leuçuta SE
    Drug Dev Ind Pharm; 2009 Sep; 35(9):1072-81. PubMed ID: 19353417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design of a timed and controlled release osmotic pump system of atenolol.
    Xue Y; Yu S; Wang H; Liang J; Peng J; Li J; Yang X; Pan W
    Drug Dev Ind Pharm; 2015 Jun; 41(6):906-15. PubMed ID: 24796273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A long acting ophthalmic gel formulations of atenolol.
    Hassan MA
    Drug Dev Ind Pharm; 2007 Nov; 33(11):1192-8. PubMed ID: 18058315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aqueous based polymeric dispersion: Plackett--Burman design for screening of formulation variables of atenolol gastrointestinal therapeutic system.
    Sastry SV; Khan MA
    Pharm Acta Helv; 1998 Jul; 73(2):105-12. PubMed ID: 9700939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of formulation solubility and hygroscopicity on disintegrant efficiency in tablets prepared by wet granulation, in terms of dissolution.
    Johnson JR; Wang LH; Gordon MS; Chowhan ZT
    J Pharm Sci; 1991 May; 80(5):469-71. PubMed ID: 1880728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compatibility of atenolol with excipients: LC-MS/TOF characterization of degradation/interaction products, and mechanisms of their formation.
    Kumar V; Shah RP; Malik S; Singh S
    J Pharm Biomed Anal; 2009 May; 49(4):880-8. PubMed ID: 19217740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transdermal atenolol releasing system: an approach towards its development.
    Gupta SP; Jain SK
    J Drug Target; 2006 Nov; 14(9):607-13. PubMed ID: 17090396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stability of amlodipine besylate and atenolol in multi-component tablets of mono-layer and bi-layer types.
    Aryal S; Skalko-Basnet N
    Acta Pharm; 2008 Sep; 58(3):299-308. PubMed ID: 19103566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Applications of excipients in the field of 3D printed pharmaceuticals.
    Tian P; Yang F; Yu LP; Lin MM; Lin W; Lin QF; Lv ZF; Huang SY; Chen YZ
    Drug Dev Ind Pharm; 2019 Jun; 45(6):905-913. PubMed ID: 30744433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymers derived from Xanthomonas campesteris and Cyamopsis tetragonolobus used as retardant materials for the formulation of sustained release floating matrix tablet of atenolol.
    Dey S; Mazumder B; Chattopadhyay S; Das MK; Sinha S; Ganguly S; De K; Mishra M
    Int J Biol Macromol; 2014 Apr; 65():346-56. PubMed ID: 24472506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.